A Study to Investigate the Antihypertensive Efficacy of MK0954

Summary

After a 4 week placebo period, patients were randomized to Placebo or Losartan 50 mg arms, after 6 weeks non-responders were up titrated to 100 mg losartan for the remaining 6 weeks. This study evaluated if losartan is more effective than placebo in lowering sitting diastolic blood pressure and is well tolerated in patients with mild to moderate hypertension.

Timeline

Start

1991-12

Primary completion

1992-08

Completion

1992-11

Drugs

Indications